Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection

This publication has 80 references indexed in Scilit:

• Prostaglandin and the Suppression of Phagocyte Innate Immune Responses in Different Organs
  Mediators of Inflammation, 2012
• Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease
  International Journal of Peptides, 2012
• Angiotensin-Converting Enzyme 2: The First Decade
  International Journal of Hypertension, 2011
• The Kidneys and Aldosterone/Mineralocorticoid Receptor System in Salt-Sensitive Hypertension
  Current Hypertension Reports, 2011
• Regulation of ACE2 in cardiac myocytes and fibroblasts
  American Journal of Physiology-Heart and Circulatory Physiology, 2008
• Increased Expression of Angiotensin Converting Enzyme 2 in Conjunction with Reduction of Neointima by Angiotensin II Type 1 Receptor Blockade
  Hypertension Research, 2008
• Renal Effects of Prostaglandins and Cyclooxygenase-2 Inhibitors
  Electrolytes & Blood Pressure, 2008
• Angiotensin-converting enzyme 2 in lung diseases
  Current Opinion in Pharmacology, 2006
• How corticosteroids control inflammation: Quintiles Prize Lecture 2005
  British Journal of Pharmacology, 2006
• The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study
  Journal of Infection, 2005